Status: Recruiting
Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study
ASPIRE will be a multi-site, prospective, two-part longitudinal, noninterventional observational cohort study of nulliparous singleton pregnant women to evaluate biomarkers from blood and ocular imaging for prediction of pregnancy complications \[i.e., preeclampsia (PE), fetal growth restriction (FGR), and gestational diabetes (GDM)\] and risk of adverse outcomes.
Participants needed: 5,500
Trial details
Age: 18-99Biological sex: FemaleType: ObservationalSponsor: Medicines360Updated: Sep 30, 2026Locations: 2
Eligibility criteria
Age ≥18 years [+3]
Multiple gestation [+4]